Items where Author is "<span class="person_name">Corkery, John M.</span>"
Number of items: 4.
Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT 7 and κ‐opioid receptors' molecular interactions and isosteric replacement. (2025)
Giuseppe Floresta,
Alberto Granzotto,
Vincenzo Patamia,
Davide Arillotta,
Gabriele D. Papanti,
Amira Guirguis,
John M. Corkery,
Giovanni Martinotti,
Stefano L. Sensi
and
Fabrizio Schifano
![]()
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). (2022)
Stefania Chiappini,
Rachel Vickers-Smith,
Amira Guirguis,
John M. Corkery,
Giovanni Martinotti,
Daniel R. Harris
and
Fabrizio Schifano
![]()
Misuse of anticholinergic medications: a systematic review. (2022)
Stefania Chiappini,
Alessio Mosca,
Andrea Miuli,
Francesco Semeraro,
Gianluca Mancusi,
Maria Chiara Santovito,
Francesco Di Carlo,
Mauro Pettorruso,
Amira Guirguis,
John M. Corkery,
Giovanni Martinotti,
Fabrizio Schifano
and
Massimo di Giannantonio
![]()
Is there a potential of misuse for Magnolia officinalis compounds/metabolites? (2017)
Fabrizio Schifano,
Valentina Guarino,
Duccio G. Papanti,
Jacopo Baccarin,
Laura Orsolini
and
John M. Corkery
![]()